Literature DB >> 2507378

Prevention of hemodynamic and vascular albumin filtration changes in diabetic rats by aldose reductase inhibitors.

R G Tilton1, K Chang, G Pugliese, D M Eades, M A Province, W R Sherman, C Kilo, J R Williamson.   

Abstract

This study investigated hemodynamic changes in diabetic rats and their relationship to changes in vascular albumin permeation and increased metabolism of glucose to sorbitol. The effects of 6 wk of streptozocin-induced diabetes and three structurally different inhibitors of aldose reductase were examined on 1) regional blood flow (assessed with 15-microns 85Sr-labeled microspheres) and vascular permeation by 125I-labeled bovine serum albumin (BSA) and 2) glomerular filtration rate (assessed by plasma clearance of 57Co-labeled EDTA) and urinary albumin excretion (determined by radial immunodiffusion assay). In diabetic rats, blood flow was significantly increased in ocular tissues (anterior uvea, posterior uvea, retina, and optic nerve), sciatic nerve, kidney, new granulation tissue, cecum, and brain. 125I-BSA permeation was increased in all of these tissues except brain. Glomerular filtration rate and 24-h urinary albumin excretion were increased 2- and 29-fold, respectively, in diabetic rats. All three aldose reductase inhibitors completely prevented or markedly reduced these hemodynamic and vascular filtration changes and increases in tissue sorbitol levels in the anterior uvea, posterior uvea, retina, sciatic nerve, and granulation tissue. These observations indicate that early diabetes-induced hemodynamic changes and increased vascular albumin permeation and urinary albumin excretion are aldose reductase-linked phenomena. Discordant effects of aldose reductase inhibitors on blood flow and vascular albumin permeation in some tissues suggest that increased vascular albumin permeation is not entirely attributable to hemodynamic changes. We hypothesize that 1) increases in blood flow may reflect impaired contractile function of smooth muscle cells in resistance arterioles and 2) increases in vascular 125I-BSA permeation and urinary albumin excretion reflect impaired vascular barrier functional integrity in addition to increased hydraulic conductance secondary to microvascular hypertension associated with decreased vascular resistance.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2507378     DOI: 10.2337/diab.38.10.1258

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  49 in total

Review 1.  Autocrine and paracrine mechanisms in the early stages of diabetic nephropathy.

Authors:  G Pugliese; F Pricci; G Romeo; G Leto; L Amadio; C Iacobini; U Di Mario
Journal:  J Endocrinol Invest       Date:  1999-10       Impact factor: 4.256

2.  Aldose reductase (AKR1B3) regulates the accumulation of advanced glycosylation end products (AGEs) and the expression of AGE receptor (RAGE).

Authors:  Shahid P Baba; Jason Hellmann; Sanjay Srivastava; Aruni Bhatnagar
Journal:  Chem Biol Interact       Date:  2011-01-27       Impact factor: 5.192

3.  Glucose-induced microvascular functional changes in nondiabetic rats are stereospecific and are prevented by an aldose reductase inhibitor.

Authors:  J R Williamson; E Ostrow; D Eades; K Chang; W Allison; C Kilo; W R Sherman
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

4.  Technetium-99m hexamethylpropylene amine oxime single-photon emission tomography of regional cerebral blood flow in insulin-dependent diabetes.

Authors:  B Keymeulen; K de Metz; R Cluydts; A Bossuyt; G Somers
Journal:  Eur J Nucl Med       Date:  1996-02

5.  Inner retinal oxygen delivery and metabolism in streptozotocin diabetic rats.

Authors:  Justin Wanek; Pang-Yu Teng; Norman P Blair; Mahnaz Shahidi
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-13       Impact factor: 4.799

6.  Sorbinil does not prevent hyperfiltration, elevated ultrafiltration pressure and albuminuria in streptozotocin-diabetic rats.

Authors:  A Körner; G Celsi; A C Eklöf; T Linné; B Persson; A Aperia
Journal:  Diabetologia       Date:  1992-05       Impact factor: 10.122

7.  Impairment of afferent arteriolar myogenic responsiveness in the galactose-fed rat is prevented by tolrestat.

Authors:  H G Forster; P M ter Wee; T C Hohman; M Epstein
Journal:  Diabetologia       Date:  1996-08       Impact factor: 10.122

8.  Intervention with the aldose reductase inhibitor, tolrestat, in renal and retinal lesions of streptozotocin-diabetic rats.

Authors:  M L McCaleb; M L McKean; T C Hohman; N Laver; W G Robison
Journal:  Diabetologia       Date:  1991-10       Impact factor: 10.122

9.  The effect of aldose reductase inhibitors on glomerular prostaglandin production and urinary albumin excretion in experimental diabetes mellitus.

Authors:  W P Chang; E Dimitriadis; T Allen; M E Dunlop; M Cooper; R G Larkins
Journal:  Diabetologia       Date:  1991-04       Impact factor: 10.122

10.  Regulation of glomerular endothelial cell proteoglycans by glucose.

Authors:  Tae-Sun Ha; Senthil Duraisamy; Jennifer L Faulkner; Balakuntalam S Kasinath
Journal:  J Korean Med Sci       Date:  2004-04       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.